Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0600
-0.0005 (-0.83%)
At close: Mar 20, 2026

Hepion Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.830.4114.7951.1991.35
Cash & Short-Term Investments
1.830.4114.7951.1991.35
Cash Growth
349.81%-97.25%-71.11%-43.96%124.30%
Prepaid Expenses
1.241.212.75.316.1
Total Current Assets
3.071.6117.4956.597.45
Property, Plant & Equipment
--0.240.130.46
Goodwill
----1.87
Other Intangible Assets
---3.193.19
Other Long-Term Assets
--0.360.430.58
Total Assets
3.071.6118.0960.24103.55
Accounts Payable
0.170.222.352.672.45
Accrued Expenses
0.080.021.744.82.51
Short-Term Debt
0.052.9---
Current Portion of Leases
--0.120.050.27
Other Current Liabilities
--1.090.372.99
Total Current Liabilities
0.33.145.297.898.21
Long-Term Leases
--0.09-0.05
Long-Term Deferred Tax Liabilities
---0.410.41
Other Long-Term Liabilities
0.10.335.432.091.89
Total Liabilities
0.43.4810.8110.3910.56
Common Stock
00000.01
Additional Paid-In Capital
247.06234.25230.29223.95224.79
Retained Earnings
-246.1-237.82-224.63-175.7-133.5
Comprehensive Income & Other
0.010.01-0.08-0.09-
Total Common Equity
0.97-3.565.5948.1691.29
Shareholders' Equity
2.67-1.867.2849.8693
Total Liabilities & Equity
3.071.6118.0960.24103.55
Total Debt
0.052.90.210.050.32
Net Cash (Debt)
1.77-2.4914.5851.1491.03
Net Cash Growth
---71.49%-43.83%127.72%
Net Cash Per Share
0.19-20.29183.55670.811295.05
Filing Date Shares Outstanding
11.6210.980.110.080.08
Total Common Shares Outstanding
11.620.140.10.080.08
Working Capital
2.77-1.5312.248.6189.25
Book Value Per Share
0.08-25.5757.96631.771197.69
Tangible Book Value
0.97-3.565.5944.9786.23
Tangible Book Value Per Share
0.08-25.5757.96589.921131.29
Machinery
--0.410.390.39
Source: S&P Global Market Intelligence. Standard template. Financial Sources.